 Christina Roark
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell, gamma-delta | 26 | 2013 | 102 | 2.520 |
Why?
| | T-Lymphocyte Subsets | 19 | 2013 | 396 | 1.910 |
Why?
| | Interleukin-17 | 9 | 2013 | 105 | 1.210 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 72 | 0.820 |
Why?
| | HLA-DRB1 Chains | 2 | 2016 | 97 | 0.680 |
Why?
| | Epitopes | 3 | 2016 | 443 | 0.650 |
Why?
| | Genetic Predisposition to Disease | 4 | 2016 | 2275 | 0.640 |
Why?
| | HLA Antigens | 2 | 2019 | 230 | 0.590 |
Why?
| | T-Lymphocytes | 7 | 2009 | 1774 | 0.510 |
Why?
| | Freund's Adjuvant | 1 | 2013 | 17 | 0.460 |
Why?
| | Collagen Type II | 2 | 2016 | 48 | 0.450 |
Why?
| | Arthritis, Rheumatoid | 3 | 2016 | 989 | 0.420 |
Why?
| | Peptides | 3 | 2016 | 879 | 0.410 |
Why?
| | Pulmonary Fibrosis | 5 | 2010 | 303 | 0.350 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 6 | 2013 | 310 | 0.280 |
Why?
| | Arthritis, Experimental | 1 | 2007 | 133 | 0.270 |
Why?
| | Mice | 30 | 2013 | 15520 | 0.270 |
Why?
| | Alleles | 3 | 2019 | 832 | 0.250 |
Why?
| | Alveolitis, Extrinsic Allergic | 3 | 2009 | 83 | 0.250 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2022 | 355 | 0.230 |
Why?
| | Transplantation, Haploidentical | 1 | 2022 | 7 | 0.220 |
Why?
| | HLA-A Antigens | 1 | 2022 | 50 | 0.220 |
Why?
| | HLA-C Antigens | 1 | 2022 | 32 | 0.210 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2022 | 177 | 0.210 |
Why?
| | HLA-B Antigens | 1 | 2022 | 55 | 0.210 |
Why?
| | Autoimmune Diseases | 3 | 2019 | 398 | 0.210 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 102 | 0.210 |
Why?
| | Mice, Inbred C57BL | 15 | 2013 | 4908 | 0.200 |
Why?
| | Ovalbumin | 5 | 2009 | 165 | 0.200 |
Why?
| | Bronchial Hyperreactivity | 3 | 2008 | 95 | 0.200 |
Why?
| | Lymph Nodes | 3 | 2013 | 455 | 0.200 |
Why?
| | Animals | 32 | 2013 | 33381 | 0.190 |
Why?
| | Mice, Inbred DBA | 2 | 2013 | 174 | 0.190 |
Why?
| | Flow Cytometry | 6 | 2016 | 1085 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2010 | 984 | 0.180 |
Why?
| | Major Histocompatibility Complex | 1 | 2001 | 220 | 0.180 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2019 | 16 | 0.170 |
Why?
| | Listeriosis | 4 | 2008 | 60 | 0.170 |
Why?
| | Mice, Knockout | 9 | 2013 | 2680 | 0.170 |
Why?
| | Respiratory Hypersensitivity | 2 | 2009 | 65 | 0.160 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3360 | 0.150 |
Why?
| | Gene Frequency | 2 | 2019 | 513 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 900 | 0.150 |
Why?
| | Hybridomas | 5 | 2005 | 233 | 0.140 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 34 | 0.140 |
Why?
| | Vimentin | 1 | 2016 | 62 | 0.140 |
Why?
| | Th17 Cells | 2 | 2013 | 57 | 0.130 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 372 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 363 | 0.130 |
Why?
| | Mice, Transgenic | 6 | 2009 | 2025 | 0.130 |
Why?
| | Lupus Nephritis | 2 | 2008 | 55 | 0.130 |
Why?
| | Peptides, Cyclic | 1 | 2016 | 260 | 0.120 |
Why?
| | Interferon-gamma | 3 | 2013 | 736 | 0.120 |
Why?
| | Inflammation | 2 | 2009 | 2566 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2016 | 625 | 0.120 |
Why?
| | Genotype | 2 | 2022 | 1882 | 0.120 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 381 | 0.120 |
Why?
| | Homeostasis | 2 | 2009 | 594 | 0.120 |
Why?
| | Glycoproteins | 2 | 2008 | 319 | 0.110 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 95 | 0.110 |
Why?
| | Haplotypes | 1 | 2014 | 473 | 0.110 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2071 | 0.100 |
Why?
| | Immunity, Innate | 2 | 2008 | 745 | 0.100 |
Why?
| | Cell Line | 2 | 2016 | 2707 | 0.100 |
Why?
| | CD8 Antigens | 2 | 2008 | 71 | 0.100 |
Why?
| | Mice, Inbred NZB | 4 | 2008 | 17 | 0.100 |
Why?
| | Protein Binding | 1 | 2016 | 1975 | 0.090 |
Why?
| | Ligands | 4 | 2022 | 567 | 0.090 |
Why?
| | Adoptive Transfer | 5 | 2009 | 204 | 0.090 |
Why?
| | Alum Compounds | 1 | 2009 | 22 | 0.090 |
Why?
| | Antibodies, Monoclonal | 4 | 2004 | 1284 | 0.090 |
Why?
| | Saccharopolyspora | 1 | 2009 | 6 | 0.090 |
Why?
| | Keratitis | 1 | 2009 | 13 | 0.090 |
Why?
| | beta 2-Microglobulin | 1 | 2009 | 47 | 0.090 |
Why?
| | Interleukins | 1 | 2010 | 242 | 0.080 |
Why?
| | Endogenous Retroviruses | 1 | 2008 | 19 | 0.080 |
Why?
| | Natural Killer T-Cells | 1 | 2009 | 62 | 0.080 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2009 | 67 | 0.080 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 130 | 0.080 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1067 | 0.080 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 96 | 0.080 |
Why?
| | Spleen | 3 | 2009 | 510 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2009 | 365 | 0.080 |
Why?
| | Humans | 11 | 2022 | 118972 | 0.080 |
Why?
| | Bacterial Infections | 1 | 2009 | 227 | 0.070 |
Why?
| | Listeria monocytogenes | 2 | 2008 | 110 | 0.070 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2007 | 170 | 0.070 |
Why?
| | Autoantibodies | 3 | 2019 | 1335 | 0.070 |
Why?
| | Autoantigens | 3 | 2008 | 397 | 0.070 |
Why?
| | Liver Diseases | 1 | 2008 | 282 | 0.070 |
Why?
| | Lung | 3 | 2010 | 3664 | 0.070 |
Why?
| | Allergens | 2 | 2009 | 424 | 0.070 |
Why?
| | Retrospective Studies | 1 | 2022 | 12978 | 0.070 |
Why?
| | Antibody Affinity | 1 | 2005 | 55 | 0.070 |
Why?
| | Genes, MHC Class II | 1 | 2005 | 72 | 0.070 |
Why?
| | Lupus Vulgaris | 1 | 2004 | 5 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2008 | 442 | 0.060 |
Why?
| | Antigens, Nuclear | 1 | 2004 | 18 | 0.060 |
Why?
| | Disease Models, Animal | 6 | 2009 | 3730 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 978 | 0.060 |
Why?
| | Retroviridae Infections | 1 | 2004 | 46 | 0.060 |
Why?
| | Bacillus subtilis | 3 | 2010 | 61 | 0.060 |
Why?
| | Leukocytes | 1 | 2005 | 290 | 0.060 |
Why?
| | Methacholine Chloride | 1 | 2003 | 48 | 0.060 |
Why?
| | Epidermis | 1 | 2003 | 152 | 0.060 |
Why?
| | Reference Values | 1 | 2003 | 774 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2005 | 359 | 0.050 |
Why?
| | Cyclophosphamide | 1 | 2022 | 222 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2022 | 89 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1206 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2005 | 632 | 0.050 |
Why?
| | Hybrid Cells | 1 | 2001 | 46 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2008 | 1753 | 0.050 |
Why?
| | Male | 6 | 2019 | 57801 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2001 | 156 | 0.050 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2005 | 702 | 0.050 |
Why?
| | Antigen-Antibody Complex | 1 | 2000 | 90 | 0.050 |
Why?
| | Child, Preschool | 1 | 2014 | 9491 | 0.040 |
Why?
| | Cytokines | 4 | 2009 | 1900 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 2019 | 123 | 0.040 |
Why?
| | Female | 8 | 2019 | 61564 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 143 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2009 | 280 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 410 | 0.040 |
Why?
| | Adult | 2 | 2019 | 31512 | 0.040 |
Why?
| | Lymphocyte Depletion | 2 | 2009 | 119 | 0.030 |
Why?
| | Solubility | 2 | 2008 | 235 | 0.030 |
Why?
| | Mice, Congenic | 2 | 2008 | 23 | 0.030 |
Why?
| | Adolescent | 1 | 2014 | 18480 | 0.030 |
Why?
| | Autoimmunity | 1 | 2001 | 831 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 827 | 0.030 |
Why?
| | Child | 1 | 2014 | 19129 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2016 | 4077 | 0.030 |
Why?
| | Immunization | 2 | 2004 | 412 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2062 | 0.020 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2010 | 36 | 0.020 |
Why?
| | Receptors, Interleukin-17 | 1 | 2009 | 5 | 0.020 |
Why?
| | Farmer's Lung | 1 | 2009 | 3 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2009 | 55 | 0.020 |
Why?
| | Receptors, Interleukin | 1 | 2009 | 41 | 0.020 |
Why?
| | Orchiectomy | 1 | 2009 | 57 | 0.020 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2008 | 39 | 0.020 |
Why?
| | Listeria | 1 | 2008 | 6 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 143 | 0.020 |
Why?
| | Interleukin-13 | 1 | 2009 | 135 | 0.020 |
Why?
| | Cornea | 1 | 2009 | 117 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2009 | 215 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 278 | 0.020 |
Why?
| | Th2 Cells | 1 | 2009 | 164 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 226 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2009 | 656 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 467 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2008 | 174 | 0.020 |
Why?
| | Complementarity Determining Regions | 1 | 2007 | 45 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2008 | 168 | 0.020 |
Why?
| | Cell Separation | 1 | 2008 | 296 | 0.020 |
Why?
| | Collagen | 1 | 2009 | 433 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 627 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2006 | 126 | 0.020 |
Why?
| | Cell Movement | 1 | 2010 | 896 | 0.020 |
Why?
| | Cell Count | 1 | 2006 | 315 | 0.020 |
Why?
| | Antigens | 1 | 2007 | 320 | 0.020 |
Why?
| | Lymphopenia | 1 | 2005 | 48 | 0.020 |
Why?
| | Interleukin-7 | 1 | 2005 | 44 | 0.020 |
Why?
| | Ambrosia | 1 | 2005 | 7 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2005 | 77 | 0.020 |
Why?
| | Hypersensitivity | 1 | 2009 | 268 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2008 | 502 | 0.020 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2004 | 12 | 0.020 |
Why?
| | Serum Albumin, Bovine | 1 | 2005 | 67 | 0.020 |
Why?
| | Antigens, Plant | 1 | 2005 | 53 | 0.020 |
Why?
| | Cross Reactions | 1 | 2004 | 116 | 0.020 |
Why?
| | Retroviridae | 1 | 2004 | 89 | 0.020 |
Why?
| | Plant Proteins | 1 | 2005 | 81 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 250 | 0.020 |
Why?
| | Myeloid Cells | 1 | 2005 | 128 | 0.020 |
Why?
| | Binding Sites, Antibody | 1 | 2004 | 38 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 314 | 0.020 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 80 | 0.020 |
Why?
| | Endopeptidases | 1 | 2004 | 73 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2004 | 205 | 0.010 |
Why?
| | Goblet Cells | 1 | 2003 | 17 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2004 | 146 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2003 | 108 | 0.010 |
Why?
| | Pulmonary Eosinophilia | 1 | 2003 | 25 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 2003 | 136 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 1781 | 0.010 |
Why?
| | Antibody Formation | 1 | 2004 | 276 | 0.010 |
Why?
| | Hyperplasia | 1 | 2003 | 170 | 0.010 |
Why?
| | Bacteria | 1 | 2009 | 757 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2326 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2424 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2490 | 0.010 |
Why?
| | Chromatin | 1 | 2004 | 441 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2003 | 384 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2004 | 788 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 138 | 0.010 |
Why?
| | Cell Membrane | 1 | 2004 | 710 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 872 | 0.010 |
Why?
| | Mutation | 1 | 2010 | 3457 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 321 | 0.010 |
Why?
| | Genetic Markers | 1 | 2000 | 348 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2445 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1795 | 0.010 |
Why?
| | Aging | 1 | 2009 | 1670 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 27617 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2004 | 963 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2275 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 6412 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2000 | 642 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2004 | 2851 | 0.010 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1993 | 9 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1993 | 2657 | 0.000 |
Why?
|
|
Roark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|